The Administrative Core remains a central component of the Moffitt PSOC. It has oversight of the disbursal of funds to the Projects and Core. It is the clearing house for communication between the Moffitt PSOC and the NCI and other members of the network. The core prepares the yearly reports to the NCI and will host the Center Advisory Committee. The Administrative Core will provide travel support for the Moffitt PSOC team, invited guest speakers, and external advisors. To foster scientific collaborations with researchers interested in related research with particular focus on physical science in oncology the Administrative Core will be responsible for the distribution of information materials, communication with other institutions, and collaborations with other relevant research programs. The admin core plays a particularly critical role in the PSOC pilot projects. The administrative core will advertise pilot funding opportunities, collect applications, organize the review panel and oversee the conduct of the funded research. These funds will be used to support exploratory clinical trials as well as unexpected avenues of investigation that arise through developments in the PSOC projects and core. Applications will be prioritized according to their (a) scientific merit, i.e. significance and feasibility; (b) centrality to the mission of the Moffitt PSOC, i.e. quantitative evolutionary dynamics of cancer, and (c) innovation, i.e. a new paradigm. There are currently 5 sources of pilot funds: 1. The PSOC budget includes $100,000 annually; 2. The Moffitt Cancer Center leadership will provide $200K per year ($1million total) for pilot studies. 3. The Moffitt Cancer Center funds an additional $50K per year to the winner of the annual IMO/PSOC transdisciplinary conference (guaranteed for the next 5 years). 4. Pilot funds from a recent gift of $500K to the Imaging and Technology Center of Excellence. This will be expanded as other gifts are received; and 5. The Radiology department research fund will provide $50K per year for image analytic pilot projects. 6. Support from the ACD for Clinical Science for the Multiple Myeloma clinical trial ? estimated to be $250K.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA193489-01A1
Application #
9024234
Study Section
Special Emphasis Panel (ZCA1-TCRB-T (O1))
Project Start
2015-09-23
Project End
2020-08-31
Budget Start
2015-09-23
Budget End
2016-08-31
Support Year
1
Fiscal Year
2015
Total Cost
$399,590
Indirect Cost
$159,088
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Subramanian, Hemachander; Gatenby, Robert A (2018) Evolutionary advantage of directional symmetry breaking in self-replicating polymers. J Theor Biol 446:128-136
Shah, Seema; Brock, Ethan J; Jackson, Ryan M et al. (2018) Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation. Neoplasia 20:951-963
Karolak, Aleksandra; Rejniak, Katarzyna A (2018) Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue. Bull Math Biol :
Shah, Seema; Brock, Ethan J; Ji, Kyungmin et al. (2018) Ras and Rap1: A tale of two GTPases. Semin Cancer Biol :
Gallaher, Jill A; Enriquez-Navas, Pedro M; Luddy, Kimberly A et al. (2018) Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies. Cancer Res 78:2127-2139
Maley, Carlo C; Aktipis, Athena; Graham, Trevor A et al. (2017) Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer 17:605-619
Ibrahim-Hashim, Arig; Robertson-Tessi, Mark; Enriquez-Navas, Pedro M et al. (2017) Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution. Cancer Res 77:2242-2254
Brown, Joel S; Cunningham, Jessica J; Gatenby, Robert A (2017) Aggregation Effects and Population-Based Dynamics as a Source of Therapy Resistance in Cancer. IEEE Trans Biomed Eng 64:512-518
Gatenby, Robert A; Brown, Joel (2017) Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer. Biochim Biophys Acta Rev Cancer 1867:162-166
Silva, Ariosto; Silva, Maria C; Sudalagunta, Praneeth et al. (2017) An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma. Cancer Res 77:3336-3351

Showing the most recent 10 out of 22 publications